Tri Chemical Laboratories Inc. (4369.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	24.8B	23.9B	18.9B	11.2B	13.8B
Cost of Revenue	4.7B	14.9B	10.9B	7.2B	8.2B
Gross Profit	2.8B	9.0B	8.0B	4.1B	5.6B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	730.5M	3.1B	2.8B	2.1B	2.1B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	730.5M	3.1B	2.8B	2.1B	2.1B
Cost and Expenses	18.5B	18.0B	13.6B	9.3B	10.3B
Operating Income (EBIT)	6.3B	5.9B	5.3B	1.9B	3.5B
Non-Operating
Interest Income	3.8M	11.3M	1.2M	710.0K	383.0K
Interest Expense	22.6M	34.4M	23.7M	23.7M	28.4M
Net Interest Income	(18.8M)	(23.1M)	(22.5M)	(23.0M)	(28.1M)
Other Non-Op Income/Expense	416.3M	1.2B	1.3B	1.3B	2.7B
Non-Operating Income (excl Interest)	440.1M	1.3B	1.4B	1.4B	2.7B
EBT (Pre-Tax Income)	2.5B	7.1B	6.6B	3.3B	6.2B
Income Tax Expense	630.0M	1.6B	1.6B	806.1M	1.4B
Bottom Line
Net Income	6.2B	5.5B	5.0B	2.5B	4.8B
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	6.2B	5.5B	5.0B	2.5B	4.8B
Per Share
Basic EPS	¥190	¥170	¥153	¥76	¥149
Diluted EPS	¥190	¥170	—	—	—
Revenue Per Share	¥763	¥735	¥582	¥346	¥425
Shares
Basic Shares Outstanding	32.5M	32.5M	32.5M	32.5M	32.5M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	2.7B	7.8B	6.6B	3.3B	4.7B
D&A	604.6M	1.9B	1.4B	1.3B	1.2B
EBIT	6.3B	5.9B	5.3B	1.9B	3.5B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Apr 1, 2026